Inspired by that, this study aimed to reveal BPTF as a novel target in the BM to predict NB progression through clinical relevance analysis, functional studies, and the molecular mechanism exploration of TFAP4 involved in BPTF carcinogenesis. The gene discussed is TFAP4; the disease is neuroblastoma.